SI1587500T1 - Sestavki za oralno dajanje učinkovin, ki potrebujejo prikritje okusa - Google Patents

Sestavki za oralno dajanje učinkovin, ki potrebujejo prikritje okusa

Info

Publication number
SI1587500T1
SI1587500T1 SI200332356T SI200332356T SI1587500T1 SI 1587500 T1 SI1587500 T1 SI 1587500T1 SI 200332356 T SI200332356 T SI 200332356T SI 200332356 T SI200332356 T SI 200332356T SI 1587500 T1 SI1587500 T1 SI 1587500T1
Authority
SI
Slovenia
Prior art keywords
compounds
active substances
oral dosage
taste masking
substances requiring
Prior art date
Application number
SI200332356T
Other languages
English (en)
Inventor
Isabelle Chacornac
Patricia Probeck
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of SI1587500T1 publication Critical patent/SI1587500T1/sl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J2/00—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic
    • B01J2/02—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops
    • B01J2/04—Processes or devices for granulating materials, e.g. fertilisers in general; Rendering particulate materials free flowing in general, e.g. making them hydrophobic by dividing the liquid material into drops, e.g. by spraying, and solidifying the drops in a gaseous medium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
SI200332356T 2002-12-23 2003-12-19 Sestavki za oralno dajanje učinkovin, ki potrebujejo prikritje okusa SI1587500T1 (sl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0216521A FR2848855B1 (fr) 2002-12-23 2002-12-23 Compositions pour administration orale de principes actifs necessitant un masquage du gout
PCT/FR2003/003813 WO2004058137A2 (fr) 2002-12-23 2003-12-19 Compositions pour administration orale de principes actifs necessitant un masquage du gout
EP03799644.4A EP1587500B1 (fr) 2002-12-23 2003-12-19 Compositions pour administration orale de principes actifs necessitant un masquage du gout

Publications (1)

Publication Number Publication Date
SI1587500T1 true SI1587500T1 (sl) 2014-07-31

Family

ID=32406402

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200332356T SI1587500T1 (sl) 2002-12-23 2003-12-19 Sestavki za oralno dajanje učinkovin, ki potrebujejo prikritje okusa

Country Status (14)

Country Link
EP (1) EP1587500B1 (sl)
JP (1) JP4676763B2 (sl)
AU (1) AU2003299360B2 (sl)
BR (1) BR0317654A (sl)
CA (1) CA2510373C (sl)
CY (1) CY1115401T1 (sl)
DK (1) DK1587500T3 (sl)
ES (1) ES2470371T3 (sl)
FR (1) FR2848855B1 (sl)
IL (1) IL169343A (sl)
MX (1) MXPA05005640A (sl)
PT (1) PT1587500E (sl)
SI (1) SI1587500T1 (sl)
WO (1) WO2004058137A2 (sl)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL1034065C2 (nl) 2007-06-29 2008-12-30 Friesland Brands Bv Bereiding van deeltjes.
FR2959130A1 (fr) 2010-04-21 2011-10-28 Sanofi Aventis Procede de preparation de compositions pharmaceutiques destinees a l'administration par voie orale comprenant un ou plusieurs principes actifs et les compositions les comprenant.
FR2968995B1 (fr) 2010-12-16 2013-03-22 Sanofi Aventis Composition pharmaceutioue pour une administration par voie orale destinee a eviter le mesusage
FR2968992B1 (fr) 2010-12-16 2013-02-08 Sanofi Aventis Comprime pharmaceutique orodispersible a base de zolpidem
FR3000400B1 (fr) 2012-12-27 2019-06-21 Virbac Suspension huileuse de metronidazole
TR201809617T4 (tr) * 2013-12-04 2018-07-23 Hovione Scientia Ltd Tat maskeleme formülasyonları içeren kontrast ortamlar.
FR3027802B1 (fr) * 2014-10-31 2018-03-02 Ethypharm Granules de principe actif a double masquage de gout, leur procede de preparation et comprimes orodispersibles les contenant

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59122425A (ja) * 1982-12-27 1984-07-14 Kaken Pharmaceut Co Ltd 持続性製剤およびその製造法
NL193682C (nl) * 1987-05-14 2000-07-04 Glaxo Group Ltd Beklede cefuroximaxetilsamenstelling.
FR2657257B1 (fr) * 1990-01-19 1994-09-02 Rhone Poulenc Sante Procede de preparation de medicaments sous forme de perles.
JP3155028B2 (ja) * 1991-06-10 2001-04-09 大川原化工機株式会社 噴霧乾燥造粒装置
JPH05309314A (ja) * 1992-05-07 1993-11-22 Sumitomo Pharmaceut Co Ltd コーティング方法
MX9306393A (es) * 1992-10-16 1994-04-29 Glaxo Group Ltd Composiciones de ranitidina substancialmente libres de sabor amargo, proceso para su preparacion y composiciones farmaceuticas que las contienen.
CN100379407C (zh) * 1997-12-19 2008-04-09 史密丝克莱恩比彻姆公司 生产咀嚼分散片的方法
JP2000103730A (ja) * 1998-07-31 2000-04-11 Otsuka Pharmaceut Co Ltd 服用感が改善された医薬組成物
US6209479B1 (en) * 1998-12-30 2001-04-03 Aeromatic-Fielder Ag Apparatus for coating tablets
CN1343128B (zh) * 1999-03-17 2010-04-21 第一制药株式会社 药物组合物

Also Published As

Publication number Publication date
WO2004058137A2 (fr) 2004-07-15
EP1587500A2 (fr) 2005-10-26
DK1587500T3 (da) 2014-06-23
IL169343A0 (en) 2007-07-04
JP4676763B2 (ja) 2011-04-27
WO2004058137A3 (fr) 2005-04-14
FR2848855B1 (fr) 2005-02-11
JP2006515592A (ja) 2006-06-01
CA2510373A1 (fr) 2004-07-15
CA2510373C (fr) 2014-09-30
MXPA05005640A (es) 2005-07-27
AU2003299360B2 (en) 2009-10-29
PT1587500E (pt) 2014-06-24
EP1587500B1 (fr) 2014-03-12
ES2470371T3 (es) 2014-06-23
CY1115401T1 (el) 2017-01-04
IL169343A (en) 2011-06-30
BR0317654A (pt) 2005-12-20
AU2003299360A1 (en) 2004-07-22
FR2848855A1 (fr) 2004-06-25

Similar Documents

Publication Publication Date Title
IL162843A0 (en) Dosage form for oral administration of a pde4 inhibitor
PL356358A1 (en) Solid dosage form of someticone for oral administration
PL368636A1 (en) Pharmaceutical dosage forms of epothilones for oral administration
HK1070285A1 (en) Pharmaceutical dosage form of amorphous nelfinavirmesylate
PT1362582E (pt) Forma de dosagem sólida revestida
HK1064035A1 (en) Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds
PL360967A1 (en) Pharmaceutical compound containing donepezyl hydrochloride
HK1107768A1 (en) Solid drug for oral use
EP1372392A4 (en) ORAL DOSAGE FORM CONTAINING NICOTINE
IL169343A0 (en) Compounds for oral dosage of active substances requiring a taste masking
PL375558A1 (en) A method of extending the dose range of vitamin d compounds
PL372773A1 (en) Oral administration of epothilones
IL166337A0 (en) Oral administration of calctionin
AU2003221699A8 (en) Pharmaceutical preparation for taste masking
EP1589950A4 (en) PROCESS FOR PREPARING PHARMACEUTICAL PHARMACEUTICAL FORMS COMPRISING ACTIVE COMPRESSION COMPONENTS
AU2003276572A1 (en) Pharmaceutical dosage forms of biguanide-sulfonylurea combinations
IL161143A0 (en) A flash-melt pharmaceutical oral dosage composition
AU2003249105A1 (en) Processes for the preparation of oral dosage formulations of modafinil
HK1072194A1 (en) Oral dosage form for controlled drug release
AU2003232652A1 (en) Oral controlled-release dosage forms containing acetaminophen
AU2003225285A1 (en) Oral dosage forms comprising fenofibrate
ZA200705012B (en) Oral solid dosage forms containing a low dose of estradiol
AU2003257102A8 (en) Pharmaceutical dosage form comprising a sulfite compound
EP1480632A4 (en) NEW DOSAGE FORM OF L-METHIONINE S-SULFOXIMINE
AU2003247001A1 (en) Processes for the preparation of oral dosage formulations of modafinil